H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
Cancer Res
; 77(24): 6999-7013, 2017 12 15.
Article
in En
| MEDLINE
| ID: mdl-29247039
Full text:
1
Database:
MEDLINE
Main subject:
Cell Transformation, Neoplastic
/
Carcinoma, Hepatocellular
/
Receptor, Fibroblast Growth Factor, Type 4
/
Fibroblast Growth Factors
/
Heterocyclic Compounds, 4 or More Rings
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Res
Year:
2017
Type:
Article